We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

79 hedge funds and large institutions have $111M invested in BioSpecifics Technologies Corp. in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

2% more capital invested

Capital invested by funds: $109M → $111M (+$1.78M)

7% less funds holding

Funds holding: 85 → 79 (-6)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
33
Reduced
24
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$1.53M
2
NC
Northpointe Capital
Michigan
+$1.46M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.34M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$1.23M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$994K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$4.05M
2
TC
TFS Capital
Pennsylvania
-$1.77M
3
Morgan Stanley
Morgan Stanley
New York
-$1.47M
4
DCM
DAFNA Capital Management
California
-$1.29M
5
BIM
Bogle Investment Management
Massachusetts
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$1.81M +$461K +11,760 +34%
RFC
27
Russell Frank Company
Washington
$1.66M -$191K -4,871 -10%
State Street
28
State Street
Massachusetts
$1.58M +$257K +6,564 +19%
Morgan Stanley
29
Morgan Stanley
New York
$1.41M -$1.47M -37,497 -51%
PI
30
Putnam Investments
Massachusetts
$1.37M -$56.1K -1,432 -4%
Goldman Sachs
31
Goldman Sachs
New York
$1.33M +$161K +4,114 +14%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$1.32M +$129K +3,304 +11%
BCM
33
Bridgeway Capital Management
Texas
$1.13M – – –
American Century Companies
34
American Century Companies
Missouri
$1M +$227K +5,797 +29%
TCIM
35
TIAA CREF Investment Management
New York
$997K -$143K -3,661 -13%
TAM
36
Tocqueville Asset Management
New York
$979K +$196K +5,000 +25%
GA
37
Geneva Advisors
Illinois
$822K +$120K +3,071 +17%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$799K -$98K -2,500 -11%
Two Sigma Investments
39
Two Sigma Investments
New York
$770K -$689K -17,587 -47%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$675K – – –
Millennium Management
41
Millennium Management
New York
$525K +$210K +5,369 +67%
Citadel Advisors
42
Citadel Advisors
Florida
$522K -$16.6K -423 -3%
ACM
43
Ativo Capital Management
Illinois
$512K -$39 -1 -0%
BG
44
BlackRock Group
United Kingdom
$512K – – –
SO
45
STRS Ohio
Ohio
$454K -$11.8K -300 -3%
BIM
46
BlackRock Investment Management
Delaware
$427K +$12.3K +315 +3%
AQR Capital Management
47
AQR Capital Management
Connecticut
$411K +$412K +10,500 New
HIM
48
Hillsdale Investment Management
Ontario, Canada
$410K -$78.4K -2,000 -16%
Wellington Management Group
49
Wellington Management Group
Massachusetts
$396K – – –
NA
50
Navellier & Associates
Nevada
$391K -$94.3K -2,407 -19%
1
2
3 4

BSTC Hedge Fund Activity: Q1 2015 in Review

79 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2015, worth a combined $111M — up 1.6% from $109M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of BSTC and 6 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 33 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $1.53M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.05M sold.

  • 79 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2015, down from 85 in Q4 2014.
  • Funds reported $111M of BioSpecifics Technologies Corp. stock for Q1 2015, up 1.6% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2015 and 12 closed out, a net change of -6 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2015 was Rice Hall James & Associates, an estimated $1.53M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2015 was Armistice Capital, an estimated $4.05M sold.

Based on aggregated 13F filings for Q1 2015.